UA91004C2 - Спосіб запобігання або зниження опосередкованої т-клітинами імунної реакції - Google Patents

Спосіб запобігання або зниження опосередкованої т-клітинами імунної реакції Download PDF

Info

Publication number
UA91004C2
UA91004C2 UAA200604170A UAA200604170A UA91004C2 UA 91004 C2 UA91004 C2 UA 91004C2 UA A200604170 A UAA200604170 A UA A200604170A UA A200604170 A UAA200604170 A UA A200604170A UA 91004 C2 UA91004 C2 UA 91004C2
Authority
UA
Ukraine
Prior art keywords
cell
cells
selectin
antibody
compound
Prior art date
Application number
UAA200604170A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Ронг-Хуа Лін
Чунг Нан ЧАНГ
Original Assignee
Абдженомикс Кооператиеф У.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/662,906 external-priority patent/US20040116333A1/en
Application filed by Абдженомикс Кооператиеф У.А. filed Critical Абдженомикс Кооператиеф У.А.
Publication of UA91004C2 publication Critical patent/UA91004C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
UAA200604170A 2003-09-15 2004-09-09 Спосіб запобігання або зниження опосередкованої т-клітинами імунної реакції UA91004C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/662,906 US20040116333A1 (en) 2001-08-03 2003-09-15 Modulators of P-selectin glycoprotein ligand 1

Publications (1)

Publication Number Publication Date
UA91004C2 true UA91004C2 (uk) 2010-06-25

Family

ID=36242362

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200604170A UA91004C2 (uk) 2003-09-15 2004-09-09 Спосіб запобігання або зниження опосередкованої т-клітинами імунної реакції

Country Status (16)

Country Link
EP (1) EP1663290A4 (pt)
JP (1) JP5808879B2 (pt)
KR (1) KR101159140B1 (pt)
CN (1) CN1852730B (pt)
AU (1) AU2004273807B2 (pt)
BR (1) BRPI0414402A (pt)
CA (1) CA2538284C (pt)
EC (1) ECSP066507A (pt)
IL (1) IL174172A (pt)
NO (1) NO20061306L (pt)
NZ (1) NZ546203A (pt)
RU (1) RU2407539C2 (pt)
SG (1) SG146670A1 (pt)
TW (2) TW201012472A (pt)
UA (1) UA91004C2 (pt)
ZA (1) ZA200602151B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2655833T3 (es) * 2004-05-11 2018-02-21 AbGenomics Coöperatief U.A. Epítopos que inducen la muerte de células T
JP5493234B2 (ja) * 2008-05-15 2014-05-14 国立大学法人 岡山大学 Ｐｓｇｌ−１阻害によるメタボリックシンドロームの予防及び治療法
IL260289B (en) * 2016-01-08 2022-08-01 Bioalliance Cv Tetravalent anti-psgl-1 antibodies and uses thereof
CN115887659A (zh) * 2022-11-23 2023-04-04 中山大学附属第七医院(深圳) 终末耗竭t细胞群“tcf19+pd1+tim3+cd8+”的鉴定及应用
CN121108302A (zh) * 2025-09-22 2025-12-12 渼达(广州)生物科技有限公司 一种重组人Fc和P-选择素的重组蛋白、检测产品及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368684B2 (en) * 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
ZA973051B (en) * 1996-04-24 1998-10-12 Genentech Inc Type c lectins
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Also Published As

Publication number Publication date
BRPI0414402A (pt) 2006-11-14
RU2407539C2 (ru) 2010-12-27
IL174172A (en) 2011-12-29
CA2538284C (en) 2015-10-20
TWI359024B (en) 2012-03-01
NO20061306L (no) 2006-06-14
AU2004273807B2 (en) 2011-06-09
IL174172A0 (en) 2006-08-01
EP1663290A2 (en) 2006-06-07
CA2538284A1 (en) 2005-03-31
ECSP066507A (es) 2006-10-10
CN1852730B (zh) 2012-05-30
KR101159140B1 (ko) 2012-06-22
AU2004273807A1 (en) 2005-03-31
JP5808879B2 (ja) 2015-11-10
ZA200602151B (en) 2013-08-28
EP1663290A4 (en) 2009-07-01
CN1852730A (zh) 2006-10-25
TW201012472A (en) 2010-04-01
TW200513262A (en) 2005-04-16
RU2006112399A (ru) 2006-08-10
KR20060088104A (ko) 2006-08-03
SG146670A1 (en) 2008-10-30
JP2007533618A (ja) 2007-11-22
NZ546203A (en) 2009-05-31

Similar Documents

Publication Publication Date Title
US8298540B2 (en) Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies
US8628775B2 (en) Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds
AU2002305041A1 (en) Modulators of P-selectin glycoprotein ligand 1
UA91004C2 (uk) Спосіб запобігання або зниження опосередкованої т-клітинами імунної реакції
EP4610277A1 (en) Method for avoiding immune rejection using agonist for inhibitory kir
HK40127630A (en) Method for avoiding immune rejection using agonist for inhibitory kir
CN121978342A (en) Cell-based assays for determining in vitro tumor killing activity of immune cells expressing chimeric antigens
KR20210043479A (ko) 이중특이성항체를 이용한 nk 세포 활성도 검사 방법 및 이와 관련된 질환의 진단 방법
HK1065489B (en) Modulators of p-selectin glycoprotein ligand 1
MXPA06002968A (en) Modulators of p-selectin glycoprotein ligand 1
HK1124624B (en) Antibody binding p-selectin glycoprotein ligand 1 (psgl-1) for use in treating allergic disease